Friday, June 19, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $298.01 +0.70%
MSFT $379.40 +0.13%
GOOGL $368.03 +1.17%
AMZN $244.39 +2.90%
TSLA $400.49 +1.04%
META $577.22 +1.70%
NVDA $210.69 +2.95%
JPM $325.22 -2.47%
BTC $27.84 -1.94%
ETH $16.21 -1.70%
AAPL
$298.01
▲ 0.70%
MSFT
$379.40
▲ 0.13%
GOOGL
$368.03
▲ 1.17%
AMZN
$244.39
▲ 2.90%
TSLA
$400.49
▲ 1.04%
META
$577.22
▲ 1.70%
NVDA
$210.69
▲ 2.95%
JPM
$325.22
▼ 2.47%
The Guardian
Move will allow Trump’s controversial pick, Bill Pulte, to assume role and remain in place for at least several weeksSign up for the Breaking News US newsletter emailDonald Trump abruptly halted the confirmation process for Jay Clayton as the US’s top intelligence chief early Wednesday, in a move that will allow Trump’s controversial selection for acting director of national security, Bill Pulte, to assume the role and remain in place for at least several weeks until Clayton is confirmed.Trump p
general  2d ago
Variety
Prime Video Spain unveiled 13 new titles plus production updates in Madrid on Wednesday, led by the announcement of a second “Zeta” movie, starring Mario Casas (“Cross the Line”), details of “Enfrentados: Marfil,” starring Ester Expósito, and first look images of “Su Majestad,’ Season 2, headed by Anna Castillo (“Nowhere”). At a Prime Video Presents […]
entertainment  2d ago
The Guardian
Republicans question details of deal set to be signed later in the week as European leaders seek to join talks. Plus: can we refreeze the Arctic?Good morning.Donald Trump, facing severe criticism from some domestic supporters for conducting a war against Iran that has met hardly any of its original objectives, has backed a joint G7 leaders’ statement that welcomes his proposed peace deal.What is the domestic criticism of the deal? Many Senate Republicans said there were still unanswered question
general  2d ago
Bloomberg Markets
UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease gene therapy before conducting a new study, a dramatic reversal that shows the Trump administration is relaxing its previous hard-line stance on drug reviews.
business  2d ago

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free